![Matthew Onaitis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Onaitis
Director Financiero/CFO en
MAINSTAY MEDICAL INTERNATIONAL
.
Perfil
Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc., and Chief Financial Officer at Mainstay Medical International Ltd. since 2018.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc (2004-2005), Associate General Counsel at Biogen, Inc. (2006), Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. (2010-2013), Secretary & General Counsel at Trius Therapeutics, Inc. (2013), Secretary & General Counsel at Ignyta, Inc. (2014-2016), and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. (2016-2018).
Education includes an undergraduate degree from Carnegie Mellon University (1993) and a graduate degree from Stanford Law School (1998).
Cargos activos de Matthew Onaitis
| Empresas | Cargo | Inicio |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Director Financiero/CFO | 20/08/2018 |
Snp Bio, Inc. | Director/Miembro de la Junta | - |
Stratify Genomics, Inc.
 Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Matthew Onaitis.
| Empresas | Cargo | Fin |
|---|---|---|
| CIDARA THERAPEUTICS | Director Financiero/CFO | 17/08/2018 |
| IGNYTA INC | Consejero General | 01/06/2016 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Consejero General | 01/12/2013 |
Somaxon Pharmaceuticals, Inc.
 Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Consejero General | 01/03/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/05/2006 |
Formación de Matthew Onaitis.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
81
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Mainstay Medical International Ltd.
 Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Develops neurostimulation therapies for people with chronic mechanical low back pain | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Stanford Law School
 Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Snp Bio, Inc. | |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Health Services |
- Bolsa de valores
- Insiders
- Matthew Onaitis
